Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Tonix Pharm Holdings (TNXP)
Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032

EQNX::TICKER_START (NASDAQ:TNXP),(NYSE:PFE),(NYSE:LLY),(NYSE:ABBV),(NYSE:MRK) EQNX::TICKER_END

TNXP : 0.3220 (+1.77%)
PFE : 27.76 (+0.76%)
LLY : 769.54 (-0.01%)
ABBV : 178.09 (+0.76%)
MRK : 129.45 (+0.15%)
Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032

TNXP : 0.3220 (+1.77%)
PFE : 27.76 (+0.76%)
LLY : 769.54 (-0.01%)
ABBV : 178.09 (+0.76%)
MRK : 129.45 (+0.15%)
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease

A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease, announcing recently that it has gotten approval from Argentina’s regulators to begin a Phase ll clinical...

OPTI.CN : 0.3100 (+6.90%)
SEEL : 0.9950 (+20.17%)
NUMI.TO : 0.1100 (unch)
NUMIF : 0.0819 (+0.61%)
ATAI : 1.8300 (unch)
OPTHF : 0.2220 (-0.58%)
TNXP : 0.3220 (+1.77%)
TAK : 14.62 (-0.14%)
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – October 5, 2022 – A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease,...

SEEL : 0.9950 (+20.17%)
TAK : 14.62 (-0.14%)
ATAI : 1.8300 (unch)
TNXP : 0.3220 (+1.77%)
OPTI.CN : 0.3100 (+6.90%)
OPTHF : 0.2220 (-0.58%)
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer's Disease

/PRNewswire/ -- A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer's disease, announcing recently that it has gotten...

OPTI.CN : 0.3100 (+6.90%)
OPTHF : 0.2220 (-0.58%)
SEEL : 0.9950 (+20.17%)
TAK : 14.62 (-0.14%)
ATAI : 1.8300 (unch)
TNXP : 0.3220 (+1.77%)
Psychedelics Use Among Young Adults Reaches All-Time High

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – September 1, 2022 – Young adults are using more hallucinogens than ever.  According to a National Institute of Health...

OPTI.CN : 0.3100 (+6.90%)
OPTHF : 0.2220 (-0.58%)
SEEL : 0.9950 (+20.17%)
NUMI.TO : 0.1100 (unch)
NUMIF : 0.0819 (+0.61%)
ATAI : 1.8300 (unch)
TNXP : 0.3220 (+1.77%)
Psychedelics Use Among Young Adults Reaches All-Time High

/PRNewswire/ -- Young adults are using more hallucinogens than ever. According to a National Institute of Health survey, the amount of people between age 19 to...

OPTI.CN : 0.3100 (+6.90%)
NUMI.TO : 0.1100 (unch)
OPTHF : 0.2220 (-0.58%)
SEEL : 0.9950 (+20.17%)
NUMIF : 0.0819 (+0.61%)
ATAI : 1.8300 (unch)
TNXP : 0.3220 (+1.77%)
Tonix Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Highlights

Phase 1 Study of TNX-801, a Vaccine in Development for the Prevention of Monkeypox and Smallpox, Expected to Initiate in First Half 2023 in Kenya; the U.S....

TNXP : 0.3220 (+1.77%)
Tonix Pharmaceuticals Announces Issuance of U.S. Patent Covering Potentiated Intranasal Oxytocin (TNX-1900) for the Treatment of Pain

New patent expected to expire in 2036 Phase 2 Study for Prevention of Migraine Headache Expected to Start Second Half 2022 CHATHAM, N.J., Aug. 01, 2022 ...

TNXP : 0.3220 (+1.77%)
Tonix Pharmaceuticals Announces Collaboration with Kenya Medical Research Institute to Develop TNX-801 in Kenya as a Vaccine for the Prevention of Monkeypox and Smallpox Infection

Phase 1 Clinical Study Expected to be Initiated in Kenya in the First Half of 2023 World Health Organization Has Declared Monkeypox a Global Health...

TNXP : 0.3220 (+1.77%)

Barchart Exclusives

3 Best Bitcoin ETFs for Passive Income
These three Bitcoin-based ETFs are solid picks for investors looking to earn a steady stream of passive income, especially if BTC prices continue to move higher. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar